Volume 5, Issue 13: Anti-pseudomonal agents for the management of P. aeruginosa infection
e-Cystic Fibrosis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Cystic Fibrosis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 5, Issue 13)
Nurses and health care professionals involved in the care of patients with Cystic Fibrosis.
After participating in this activity, the participant will demonstrate the ability to:
- Describe recent clinical trials of inhaled antibiotics for treatment of chronic
- Summarize new findings describing P. aeruginosa airway dynamics and biofilm antibiotics susceptibility testing in acute CF pulmonary exacerbations P. aeruginosa infection.
- Discuss the impact of treatment with CFTR correctors/potentiators on chronic P. aeruginosa infection.
Ottawa Hospital Research Institute
University of Ottawa
Dr. Shawn Aaron reports he has no relevant relationships with a commercial entity.
Dr. Shawn Aaron reports there will be no discussions of off-label or unapproved uses of drugs or products.
- 1.00 ANCC
- 1.00 Attendance